Expression of the c-kit (CD117) Molecule in Normal and Malignant Hematopoiesis

References

• Yarden Y., Kuang W.J., Yang Feng T., Coussens L., Munemitsu S., Dull T.J., Chen E., Schlessinger J., Francke U., Ullrich A. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 1987; 6: 3341–3351
   PubMed Web of Science ®Google Scholar
• Qiu F.H., Ray P., Brown K., Barker P.E., Jhanwar S., Ruddle F.H., Besmer P. Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family -oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J. 1988; 7: 1003–1011
   PubMed Web of Science ®Google Scholar
• Ashman L.K., Cambareri A.C., To L.B., Levinsky R.J., Juttner C.A. Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood 1991; 78: 30–37
   PubMed Web of Science ®Google Scholar
• Ogawa M., Matsuzaki Y., Nishikawa S., Hayashi S., Kunisada T., Sudo T., Kina T., Nakauchi H. Expression and function of c-kit in hemopoietic progenitor cells. J. Exp. Med. 1991; 174: 63–71
   PubMed Web of Science ®Google Scholar
• Papayannopoulou T., Bice M., Broudy V.C., Zsebo K.M. Isolation of c-kit receptor expressing cells from bone marrow, peripheral blood, and fetal liver: functional properties and composite antigenic profile. Blood 1991; 78: 1403–1412
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y., Gunji Y., Nakamura M., Hayakawa K., Maeda M., Osawa H., Nagayoshi K., Kasahara T., Suda T. Expression of c-kit mRNA and protein during the differentiation of human hematopoietic progenitor cells. Exp. Hematol 1993; 21: 1233–1238
   PubMed Web of Science ®Google Scholar
• Reisbach G., Bartke I., Kempkes B., Kostka G., Ellwart J., Birner A., Thalmeier K., Mailhammer R., Bornkamm G.W., Ullrich A., et al. Characterization of hemopoietic cell populations from human cord blood expressing c-kit. Exp. Hematol 1993; 21: 74–79
   PubMed Web of Science ®Google Scholar
• Cambareri A.C., Ashman L.K., Cole S.R., Lyons A.B. A monoclonal antibody to a human mast cell/myeloid leukaemia-specific antigen binds to normal haemopoietic progenitor cells and inhibits colony formation in vitro. Leuk. Res. 1988; 12: 929–939
   PubMed Web of Science ®Google Scholar
• Valent P., Ashman L.K., Hinterberger W., Eckersberger F., Majdic O., Lechner K., Bettelheim P. Mast cell typing: Demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. Blood 1989; 73: 1778–1785
   PubMed Web of Science ®Google Scholar
• Valent P., Majdic O., Maurer D., Bodger M., Muhm M., Bettelheim P. Further characterization of surface membrane structures expressed on human basophils and mast cells. Int. Arch. Allergy, Appl. Immunol. 1990; 91: 198–203
   PubMedGoogle Scholar
• Krilis S.A., Wameford S.G., Macpherson J., Kyradji S., Dalla-Pozza L., Kemp A., Mitchell R., Chesterman C.N., Rowe P.B., Symonds G. Establishment in culture and characterization of a strain with mast cell and monocytic properties from the bone marrow of a child with diffuse cutaneous mastocytosis. Blood 1991; 78: 290–303
   PubMed Web of Science ®Google Scholar
• Matsui Y., Zsebo K.M., Hogan B.L. Embryonic expression of a haematopoietic growth factor encoded by the SI locus and the ligand for c-kit. Nature 1990; 347: 667–669
   PubMed Web of Science ®Google Scholar
• Dippel E., Haas N., Grabbe J., Schadendorf D., Hamann K., Czametzki B.M. Expression of the c-kit receptor in hypomelanosis: A comparative study between piebaldism, naevus depigmentosus and vitiligo. Br. J. Dermatol. 1995; 132: 182–189
   PubMed Web of Science ®Google Scholar
• Manova K., Nocka K., Besmer P., Bachvarova R.F. Gonadal expression of c-kit encoded at the W locus of the mouse. Development 1990; 110: 1057–1069
   PubMed Web of Science ®Google Scholar
• Orr Urtreger A., Avivi A., Zimmer Y., Givol D., Yarden Y., Lonai P. Developmental expression of c-kit, a proto-oncogene encoded by the W locus. Development 1990; 109: 911–923
   PubMed Web of Science ®Google Scholar
• Strohmeyer T., Reese D., Press M., Ackermann R., Hartmann M., Slamon D. Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue. J. Urol. 1995; 153: 511–515
   PubMed Web of Science ®Google Scholar
• Hirata T., Morii E., Morimoto M., Kasugai T., Tsujimura T., Hirota S., Kanakura Y., Nomura S., Kitamura Y. Stem cell factor induces outgrowth of c-kit-positive neurites and supports the survival of c-kit-positive neurons in dorsal root ganglia of mouse embryos. Development 1993; 119: 49–56
   PubMed Web of Science ®Google Scholar
• Ida J.A., Jr, Dubois-Dalcq M., McKinnon R.D. Expression of the receptor tyrosine kinase c-kit in oligodendrocyte progenitor cells. J. Neurosci. Res. 1993; 36: 596–606
   PubMed Web of Science ®Google Scholar
• Morii E., Hirata T., Hirota S., Kosaka J., Kim H.-M., Ito A., Sugimoto T., Kitamura Y., Nomura S. Types of neurons that express mRNA of c-kit and its ligand in developing murine cerebellum. Acta. Histochem. Cytochem. 1993; 26: 359–364
   Google Scholar
• Cohen P.S., Chan J.P., Lipkunskaya M., Biedler J.L., Seeger R.C., Children's Cancer Group. Expression of stem cell factor and c-kit in human neuroblastoma. Blood 1994; 84: 3465–3472
   PubMed Web of Science ®Google Scholar
• Miyamoto T., Sasaguri Y., Sugama K., Azakami S., Morimatsu M. Expression of the c-kit mRNA in human aortic endothelial cells. Biochem. Mol. Biol. Int. 1994; 34: 513–520
   PubMedGoogle Scholar
• Toyota M., Hinoda Y., Takaoka A., Makiguchi Y., Takahashi T., Itoh F., Imai K., Yachi A. Expression of c-kit and kit ligand in human colon carcinoma cells. Tumor Biol 1993; 14: 295–302
   PubMed Web of Science ®Google Scholar
• Inoue M., Kyo S., Fujita M., Enomoto T., Kondoh G. Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors. Cancer Res. 1994; 54: 3049–3053
   PubMed Web of Science ®Google Scholar
• Anderson D.M., Lyman S.D., Baird A., Wignall J.M., Eisenman J., Rauch C., March C.J., Boswell H.S., Gimpel S.D., Cosman D., et al. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 1990; 63: 235–243
   PubMed Web of Science ®Google Scholar
• Huang E., Nocka K., Beier D.R., Chu T.Y., Buck J., Lahm H.W., Wellner D., Leder P., Besmer P. The hematopoietic growth factor KL is encoded by the S1 locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 1990; 63: 225
   PubMed Web of Science ®Google Scholar
• Williams D.E., Eisenman J., Baird A., Rauch C., Van Ness K., March C.J., Park L.S., Martin U., Mochizuki D.Y., Boswell H.S., et al. Identification of a ligand for the c-kit proto-oncogene. Cell 1990; 63: 167–174
   PubMed Web of Science ®Google Scholar
• Zsebo K.M., Williams D.A., Geissler E.N., Broudy V.C., Martin F.H., Atkins H.L., Hsu R.Y., Birkett N.C., Okino K.H., Murdock D.C., et al. Stem cell factor is encoded at the S1 locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990; 63: 213–224
   PubMed Web of Science ®Google Scholar
• Copeland N.G., Gilbert D.J., Cho B.C., Donovan P.J., Jenkins N.A., Cosman D., Anderson D., Lyman S.D., Williams D.E. Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell 1990; 63: 175–183
   PubMed Web of Science ®Google Scholar
• Flanagan J.G., Leder P. The kit ligand: a cell surface molecule altered in steel mutant fibroblasts. Celt 1990; 63: 185–194
   PubMed Web of Science ®Google Scholar
• Andrews R.G., Knitter G.H., Barteltnez S.H., Langley K.E., Farrar D., Hendren R.W., Appelbaum F.R., Bernstein I.D., Zsebo K.M. Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates. Blood 1991; 78: 1975–1980
   PubMed Web of Science ®Google Scholar
• Bernstein I.D., Andrews R.G., Zsebo K.M. Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin- cells, and the generation of colony-forming cell progeny from CD34+lin- cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor. Blood 1991; 11: 2316–2321
   Google Scholar
• Broxmeyer H.E., Cooper S., Lu L., Hangoc G., Anderson D., Cosman D., Lyman S.D., Williams D.E. Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells. Blood 1991; 77: 2142–2149
   PubMed Web of Science ®Google Scholar
• Carow C.E., Hangoc G., Cooper S.H., Williams D.E., Broxmeyer H.E. Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with a high replating potential. Blood 1991; 78: 2216–2221
   PubMed Web of Science ®Google Scholar
• McNiece I.K., Langley K.E., Zsebo K.M. Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp. Hematol. 1991; 19: 226–231
   PubMed Web of Science ®Google Scholar
• Avraham H., Scadden D.T., Chi S., Broudy V.C., Zsebo K.M., Groopman J.E. Interaction of human bone marrow fibroblasts with megakaryocytes: role of the c-kit ligand. Blood 1992; 80: 1679–1684
   PubMed Web of Science ®Google Scholar
• Avraham H., Vannier E., Cowley S., Jiang S.X., Chi S., Dinarello C.A., Zsebo K.M., Groopman J.E. Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells. Blood 1992; 79: 365–371
   PubMed Web of Science ®Google Scholar
• Galli S.J., Tsai M., Wershil B.K. Regulation of mast cell proliferation, maturation and function by stem cell factor, a ligand for the c-kit receptor. Int. Arch. Allergy Immunol. 1992; 99: 234–237
   PubMed Web of Science ®Google Scholar
• Ratajezac M.Z., Luger S.M., Gewirtz A.M. The c-kit proto-oncogene in normal and malignant human hematopoiesis. Int. J. Cell Cloning 1992; 10: 205–214
   PubMedGoogle Scholar
• Abboud M.R., Xu F., Payne A., Laver J. Effects of recombinant human Steel factor (c-kit ligand) on early cord blood hematopoietic precursors. Exp. Hematol 1994; 22: 388–392
   PubMed Web of Science ®Google Scholar
• Verfaillie C., Hurley R., Bhatia R., McCarthy J.B. Role of bone marrow matrix in normal and abnormal hematopoiesis. Crit. Rev. Oncol. Hematol 1994; 16: 201–224
   PubMed Web of Science ®Google Scholar
• Keller J.R., Ortiz M., Ruscetti F.W. Steel factor (c-kit ligand) promotes the survival of hematopoietic stem/progenitor cells in the absence of cell division. Blood 1995; 86: 1757–1764
   PubMed Web of Science ®Google Scholar
• Flanagan J.G., Chan D.C., Leder P. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sid mutant. Cell 1991; 64: 1025–1035
   PubMed Web of Science ®Google Scholar
• Adachi S., Ebi Y., Nishikawa S., Hayashi S., Yamazaki M., Kasugai T., Yamamura T., Nomura S., Kitamura Y. Necessity of extracellular domain of W (c-kit) receptors for attachment of murine cultured mast cells to fibroblasts. Stood 1992; 79: 650–656
   Google Scholar
• Tono T., Tsujimura T., Koshimizu U., Kasugai T., Adachi S., Isozaki K., Nishikawa S., Morimoto M., Nishimune Y., Nomura S., et al. c-kit Gene was not transcribed in cultured mast cells of mast cell-deficient Wsh/Wsh mice that have a normal number of erythrocytes and a normal c-kit coding region. Blood 1992; 80: 1448–1453
   PubMed Web of Science ®Google Scholar
• Kodama H., Nose M., Niida S., Nishikawa S., Nishikawa S.-I. Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells. Exp. Hematol 1994; 22: 979–984
   PubMed Web of Science ®Google Scholar
• Hoffman R., Tong J., Brandt J., Traycoff C., Bruno E., McGuire B.W., Gordon M.S., McNiece I., Srour E.F. The in vitro and in vivo effects of stem cell factor on human hematopoiesis. Stem Cells Dayt. 1993; 11(Suppl 2)76–82
   PubMedGoogle Scholar
• McNiece I.K., Briddell R.A., Hartley C.A., Andrews R.G. The role of stem cell factor in mobilization of peripheral blood progenitor cells: synergy with G-CSF. Stem Cells Dayt. 1993; 11 Suppl 3: 83–88
   PubMed Web of Science ®Google Scholar
• McNiece I.K., Briddell R.A., Hartley C.A., Smith K.A., Andrews R.G. Stem cell factor enhances in vivo effects of granulocyte colony stimulating factor for stimulating mobilization of peripheral blood progenitor cells. Stem Cells Dayt. 1993; 11(Suppl 2)36–41
   PubMedGoogle Scholar
• Tong J., Gordon M.S., Srour E.F., Cooper R.J., Orazi A., McNiece I., Hoffman R. In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cells. Blood 1993; 82: 784–791
   PubMed Web of Science ®Google Scholar
• Gadd S.J., Ashman L.K. A murine monoclonal antibody specific for a cell-surface antigen expressed by a subgroup of human myeloid leukaemias. Leuk. Res. 1985; 9: 1329–1336
   PubMed Web of Science ®Google Scholar
• Lerner N.B., Nocka K.H., Cole S.R., Qiu F.H., Strife A., Ashman L.K., Besmer P. Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 1991; 77: 1876–1883
   PubMed Web of Science ®Google Scholar
• Orfao A., Ruiz-Arguelles A., Lacombe F., Ault K., Basso G., Danova M. Flow cytometry: Its applications in hematology. Haematologica 1995; 80: 69–81
   PubMedGoogle Scholar
• Orfao A., Ciudad J., Gonzalez M., Lopez A., Del Mar Abad M., Paz Bouza J.I., Cruz J.J., Gomez Alonso A., San Miguel J.F. Flow cytometry in the diagnosis of cancer. Scand. J. Clin. Lab. Invest. 55 Suppl. 1995; 221: 145–152
   PubMedGoogle Scholar
• Gross H.J., Verwer B., Houck D., Recktenwald D. Detection of rare cells at a frequency of one per million by flow cytometry. Cytometry 1993; 14: 519–526
   PubMedGoogle Scholar
• Gross H.J., Verwer B., Houck D., Hoffman R.A., Recktenwald D. Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10-7. Proc. Natl Acad. Sci. U.S.A. 1995; 92: 537–541
   PubMed Web of Science ®Google Scholar
• Radbruch A., Recktenwald D. Detection and isolation of rare cells. Curr. Opin. Immunol 1995; 7: 270–273
   PubMed Web of Science ®Google Scholar
• De Jong M.O., Wagemaker G., Wognum A.W. Separation of myeloid and erythroid progenitors based on expression of CD34 and c-kit. Blood 1995; 86: 4076–4085
   PubMed Web of Science ®Google Scholar
• Macedo A., Orfao A., Martinez A., Vidriales M.B., Valverde B., Lopez-Berges M.C., San Miguel J.F. Immunophenotype of c-kit cells in normal human bone marrow: Implications for the detection of minimal residual disease in AML. Br. J. Haematol 1995; 89: 338–341
   PubMed Web of Science ®Google Scholar
• Macedo A., Orfao A., Vidriales M.B., Lopez-Berges M.C., Valverde B., Gonzalez M., Caballero M.D., Ramos F., Martinez M., Femandez-Calvo J., Martinez A., San Miguel J.F. Characterization of aberrant pheno-types in acute myeloblastic leukemia. Ann. Hematol 1995; 70: 189–194
   PubMed Web of Science ®Google Scholar
• Gunji Y., Nakamura M., Osawa H., Nagayoshi K., Nakauchi H., Miura Y., Yanagisawa M., Suda T. Human primitive hematopoietic progenitor cells are more enriched in KITlow cells than in KIThigh cells. Blood 1993; 82: 3283–3289
   PubMed Web of Science ®Google Scholar
• Uoshima N., Ozawa M., Kimura S., Tanaka K., Wada K., Kobayashi Y., Kondo M. Changes in c-Kit expression and effects of SCF during differentiation of human erythroid progenitor cells. Br. J. Haematol. 1995; 91: 30–36
   PubMed Web of Science ®Google Scholar
• Kubota A., Okamura S., Shimoda K., Ikematsu W., Otsuka T., Niho Y. Analysis of c-kit expression of human erythroleukemia cell line, HEL: Clonal variation and relationship with erythroid and megakaryocytic phenotype. Leuk. Res. 1995; 19: 283–290
   PubMed Web of Science ®Google Scholar
• Orfao A., Escribano L., Villarrubia J., Velasco J.L., Cervero C., Ciudad J., Navarro J.L., San Miguel J.F. Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples. Identification and enumeration. Am. J. Pathol 1996; 149: 1493–1499
   PubMed Web of Science ®Google Scholar
• Villarrubia J., Díaz Agustín B., Cerveró C., Velasco J.L., Ciudad J., Orfao A., San Miguel J.F., Navarro J.L., Escribano L. Immunophenotype of human bone marrow mast cells in normal controls and in different hematologic malignancies. Sangre 1996; 41(Suppl 3)59, Abstract
   PubMedGoogle Scholar
• Díaz Agustín B., Escribano L., Orfao A., Villarrubia J., Velasco J.L., Cerveró C., Sanchez A., Nunˆez R., Herrera P., Bravo P., Quiroga R., Navarro J.L., San Miguel J.F. Immunophenotypical diagnosis of indolent systemic mast cell disease. Sangre 1996; 41(Suppl 3)59, Abstract
   PubMedGoogle Scholar
• Escribano L., Orfao A., Villarrubia J., Cerveró C., Velasco J.L., Martin F., San Miguel J.F., Navarro J.L. Expression of lymphoid-associated antigens in blood and bone marrow mast cells in a case of systemic mast cell disease. Br. J. Haematol 1995; 91: 941–943
   PubMed Web of Science ®Google Scholar
• Escribano L., Orfao A., Villarrubia J., Martín F., Madruga J.I., Cuevas M., Velasco J.L., Rios A., San Miguel J.F. Sequential immunophenorypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia. Cytometry 1997; 30: 98–102
   PubMedGoogle Scholar
• Matos M.E., Schnier G.S., Beecher M.S., Ashman L.K., Williams D.E., Caligiuri M.A. Expression of a functional c-kit receptor on a subset of natural killer cells. J. Exp. Med. 1993; 178: 1079–1084
   PubMed Web of Science ®Google Scholar
• Carson W.E., Haldar S., Baiocchi R.A., Croce C.M., Caligiuri M.A. The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2. Proc. Natl. Acad. Sci. U.S.A. 1994; 91: 7553–7557
   PubMed Web of Science ®Google Scholar
• DeCastro C.M., Denning S.M., Langdon S., Vandenbark G.R., Kurtzberg J., Scearce R., Haynes B.F., Kaufman R.E. The c-kit proto-oncogene receptor is expressed on a subset of human CD3−CD4−CD8− (triple-negative) thymocytes. Exp. Hematol. 1994; 22: 1025–1033
   PubMed Web of Science ®Google Scholar
• Matsuzaki Y., Gyotoku J., Ogawa M., Nishikawa S., Katsura Y., Gachelin G., Nakauchi H. Characterization of c-kit positive intrathymic stem cells that are restricted to lymphoid differentiation. J. Exp. Med. 1993; 178: 1283–1292
   PubMed Web of Science ®Google Scholar
• Takeda S., Shimizu T., Rodewald H.R. Interactions between c-kit and stem cell factor are not required for B-cell development in vivo. Blood 1997; 89: 518–525
   PubMed Web of Science ®Google Scholar
• Ashman L.K., Roberts M.M., Gadd S.J., Cooper S.J., Juttner C.A. Expression of a 150-kD cell surface antigen identified by monoclonal antibody YB5.B8 is associated with poor prognosis in acute non-lymphoblastic leukaemia. Leuk. Res. 1988; 12: 923–928
   PubMed Web of Science ®Google Scholar
• Buhring H.J., Ullrich A., Schaudt K., Muller C.A., Busch F.W. The product of the proto-oncogene c-kit is a human bone marrow surface antigen of hemopoietic precursor cell which is expressed on a subset of acute non-lymphoblastic leukemic cells. Leukemia 1991; 5: 854–860
   PubMed Web of Science ®Google Scholar
• Kubota A., Okamura S., Shimoda K., Harada M., Niho Y. The c-kit molecule and the surface immunophenotype of human acute leukemia. Leuk. Lymphoma 1994; 14: 421–428
   PubMed Web of Science ®Google Scholar
• Reuss-Borst M.A., Buhring H.J., Schmidt H., Muller C.A. AML: Immunophenotypic heterogeneity and prognostic significance of c-kit expression. Leukemia 1994; 8: 258–263
   PubMed Web of Science ®Google Scholar
• Lauria F., Bagnara G.P., Rondelli D., Raspadori D., Strippoli P., Bonsi L., Ventura M.A., Montanaro L.L., Bubola G., Tura S., Broudy V.C. Cytofluorimetric and functional analysis of c-kit receptor in acute leukemia. Leuk. Lymphoma 1995; 18: 451–455
   PubMed Web of Science ®Google Scholar
• Muroi K., Nakamura M., Amemiya Y., Suda T., Miura Y. Expression of c-kit receptor (CD117) and CD34 in leukemic cells. Leuk. Lymphoma 1995; 16: 297–305
   PubMed Web of Science ®Google Scholar
• Valverde L.R., Matutes E., Farahat N., Heffernan A., Owusu-Ankomah K., Morilla R., Catovsky D. C-kit receptor (CD117) expression in acute leukemia. Ann. Hematol. 1996; 72: 11–15
   PubMed Web of Science ®Google Scholar
• Wells S.J., Bray R.A., Stempora L.L., Farhi D.C. CD117/CD34 expression in leukemic blasts. Am. J. Clin. Pathol 1996; 106: 192–195
   PubMed Web of Science ®Google Scholar
• Nishii K., Kita K., Miwa H., Kawakami K., Nakase K., Masuya M., Morita N., Omay S.B., Otsuji N., Fukumoto M., et al. c-kit gene expression in CD7-positive acute lymphoblastic leukemia: close correlation with expression of myeloid-associated antigen CD13. Leukemia 1992; 6: 662–668
   PubMed Web of Science ®Google Scholar
• Miwa H., Nakase K., Kita K. Biological characteristics of CD7(+) acute leukemia. Leuk. Lymphoma. 1996; 21: 239–244
   PubMed Web of Science ®Google Scholar
• Dunphy C.H., Gregowicz A.J., Rodriguez G., Jr. Natural killer cell acute leukemia with myeloid antigen expression: A previously undescribed form of acute leukemia. Am. J. Clin. Pathol. 1995; 104: 212–215
   PubMed Web of Science ®Google Scholar
• Hu Z.-B., Ma W., Uphoff C.C., Quentmeier H., Drexler H.G. c-kit expression in human megakary-oblastic leukemia cell lines. Blood 1994; 83: 2133–2144
   PubMed Web of Science ®Google Scholar
• Lemoli R.M., Fortuna A., Grande A., Gamberi B., Bonsi L., Fogli M., Amabile M., Cavo M., Ferrari S., Tura S. Expression and functional role of c-kit ligand (SCF) in human multiple myeloma cells. Br. J. Haematol 1994; 88: 760–769
   PubMed Web of Science ®Google Scholar
• Ocqueteau M., Orfao A., García-Sanz R., Almeida J., Gonzalez M., San Miguel J.F. Expression of the CD117 antigen (C-Kit) on normal and myelomatous plasma cells. Br. J. Haematol 1996; 95: 489–493
   Google Scholar
• San Miguel J.F., Almeida J., Ocqueteau M., Orfao A. Detection of two subpopulations of plasma cells in MGUS patients. Utility in the differential diagnosis with multiple myeloma. Blood 1997; 88(Suppl 1)2550, Abstract
   Google Scholar